Results 231 to 240 of about 5,411,820 (260)

Disease course after pregnancy in women with progressive multiple sclerosis symptoms. [PDF]

Mult Scler
Shipley J, Beadnall HN, Sanfilippo PG, Horakova D, Boz C, Prat A, Ozakbas S, Kalincik T, Roos I, Altintas A, Eichau S, Skibina O, Alroughani R, Patti F, Etemadifar M, Lugaresi A, Tomassini V, Butzkueven H, van der Walt A, Jokubaitis VG.   +19 more
europepmc   +1 more source

Progress report on new epilepsy treatments: A summary of the Eighteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVIII). II. Treatments in more advanced clinical development

Epilepsia, EarlyView.
Abstract This article summarizes data for 13 investigational treatments for which at least preliminary seizure outcome data in patients with epilepsy were reported at the Eighteenth Eilat Conference on New Antiepileptic Drugs and Devices held in Madrid, Spain, on May 3–6, 2026.
Meir Bialer, Cecilie Johannessen Landmark, Matthias J. Koepp, Emilio Perucca, Piero Perucca, Torbjörn Tomson, H. Steve White, Elaine Wirrell   +7 more
wiley   +1 more source

Vascular Comorbidities and an Increased Comorbidity Score Are Associated With Disability and Disability Progression in Secondary Progressive Multiple Sclerosis. [PDF]

Eur J Neurol
John NA, Li Y, Angelis F, Carrasco FP, Stutters J, Doshi A, Calvi A, Plantone D, Williams T, Phan T, Chataway J, MS‐SMART Investigators.   +11 more
europepmc   +1 more source

Demyelinated lesion associated compartmental inflammation in progressive multiple sclerosis brains. [PDF]

Acta Neuropathol Commun
Najm L, Chomyk A, Cyncynatus K, Davalos D, Mahajan KR, Trapp BD.   +5 more
europepmc   +1 more source

Evaluation of cortical pathology in primary-progressive multiple sclerosis: a post hoc analysis of the SPRINT-MS trial. [PDF]

BMJ Neurol Open
Krijnen EA, Bruijn AM, Eloyan A, Schoonheim MM, Fox RJ, Klawiter EC.   +5 more
europepmc   +1 more source

Efficacy and safety of mesenchymal stem cell transplantation for progressive multiple sclerosis: a systematic review and meta-analysis of randomized controlled trials with clinical implications for patient stratification and treatment optimization. [PDF]

Front Immunol
Guo H, Zeng L, Sun L.
europepmc   +1 more source

Stool Glial Fibrillary Acidic Protein Is Elevated in Progressive Multiple Sclerosis. [PDF]

Neurol Neuroimmunol Neuroinflamm
Schwerdtfeger LA, Montini F, Antonini Cencicchio M, Christenson JR, Glanz BI, Falcone M, Filippi M, Cox LM, Chitnis T, Weiner HL.   +9 more
europepmc   +1 more source

Patient Experiences with Relapsing-Remitting and Primary Progressive Multiple Sclerosis: Development of a Conceptual Model to Inform Clinical Outcome Assessment Evaluation. [PDF]

Neurol Ther
Seçinti E, Barrett L, Delbecque L, Hoyt M, Rosenberg-Yunger Z, Baldasaro J, Schmidt K, Mills J, Cano S, Gandhy C, Curtis SE.   +10 more
europepmc   +1 more source

MPHOSPH9/CDK2AP1 and RGS1 are novel multiple sclerosis susceptibility loci

, 2010
COMI , GIANCARLO, International Multiple Sclerosis Genetics Consortium   +1 more
core